Patent · US Active

ADAMTS-13 mutant

US8906661B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 28, 2014
Grant dateDec 9, 2014
Priority date—
Expiry dateJan 28, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/24087
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.